feel any pain.
Beyond clinical trials, the technology has made a meaningful impact in realworld settings. At the Heim Pál National Pediatric Institute in Hungary, N-FIS has been used for over 4,000 haematology-oncology patients, drastically reducing injection-related distress. In India, leading hospitals including Cloudnine, KEM, Apollo Cradle, KIMS, and Rainbow Children’ s Hospital have adopted the device, with nearly 1,000 doctors across Tier 1 and Tier 2 cities actively using it to enhance patient care and compliance.
N-FIS isn’ t just replacing the needle, it’ s replacing fear with confidence and comfort, especially for the people who need it most.
What is the current size of the global and Indian injection market? How are you positioning the N-FIS in India and how has been the market response?
The global market for needle-free injectors is projected to grow substantially, reaching an estimated value of $ 27.65 billion by 2028 at a compound annual growth rate of 14.16 percent. While traditional syringes continue to dominate, rising concerns around pain, safety, and environmental sustainability are
heathtech
BIOVOICENEWS. COM 45